Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)
Completed
Conditions studied: Anemia, Cooley's, Beta-Thalassemia, Hematologic Diseases, Thalassemia, Osteoporosis, Iron Overload, Hypertension, Pulmonary
In brief
The purpose of the TCRN is to accelerate research in the management of thalassemia, standardize existing treatments, and evaluate new ones in a network of clinical centers in North America. The emphasis will be on clinical trials that help identify optimal therapy. Therapeutic trials may involve investigational drugs, drugs already approved but not currently used, and drugs currently used.
Key facts
- Study ID
- NCT00000623
- Run by
- Carelon Research
- People needed
- 1000
- Starts
- 2000-07-01
- Expected to finish
- 2006-07-01
- Last updated by the study team
- 2014-03-04
Who can join
Age: 1 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Children's Hospital Oakland — Oakland, California, United States
- Children's Hospital — Boston, Massachusetts, United States
- Weill Medical College of Cornell University — New York, New York, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- Toronto General Hospital — Toronto, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.